Taigen Biopharmaceuticals Holdings Ltd (4157) — Working Capital to Net Assets Ratio
Taigen Biopharmaceuticals Holdings Ltd (4157) has a Working Capital to Net Assets ratio of 95.0% as of June 2026. Working capital of NT$971.00 Million (current assets of NT$1.00 Billion minus current liabilities of NT$31.49 Million) is measured against net assets of NT$1.02 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Taigen Biopharmaceuticals Holdings Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Taigen Biopharmaceuticals Holdings Ltd Working Capital to Net Assets (2010–2025)
This chart shows how Taigen Biopharmaceuticals Holdings Ltd's Working Capital to Net Assets ratio has evolved across 16 annual periods from 2010 to 2025. As of June 2026, the ratio stands at 95.0%, reflecting working capital of NT$971.00 Million against net assets of NT$1.02 Billion TWD. For the complete balance sheet picture, see Taigen Biopharmaceuticals Holdings Ltd total assets.
Annual Working Capital to Net Assets for Taigen Biopharmaceuticals Holdings Ltd (2010–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Taigen Biopharmaceuticals Holdings Ltd from 2010 to 2025, covering 16 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Taigen Biopharmaceuticals Holdings Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 96.5% | NT$1.04 Billion | NT$1.07 Billion | NT$1.12 Billion | NT$83.11 Million | ▲ +0.4 pp |
| 2024 | 96.1% | NT$1.04 Billion | NT$1.08 Billion | NT$1.09 Billion | NT$46.08 Million | ▲ +1.1 pp |
| 2023 | 95.0% | NT$1.06 Billion | NT$1.12 Billion | NT$1.11 Billion | NT$47.89 Million | ▲ +2.4 pp |
| 2022 | 92.6% | NT$897.91 Million | NT$970.03 Million | NT$949.24 Million | NT$51.32 Million | ▲ +1.5 pp |
| 2021 | 91.1% | NT$1.14 Billion | NT$1.25 Billion | NT$1.23 Billion | NT$89.88 Million | ▲ +24.0 pp |
| 2020 | 67.1% | NT$296.69 Million | NT$442.18 Million | NT$391.60 Million | NT$94.91 Million | ▼ -8.3 pp |
| 2019 | 75.4% | NT$614.51 Million | NT$815.18 Million | NT$703.82 Million | NT$89.31 Million | ▲ +5.9 pp |
| 2018 | 69.5% | NT$759.75 Million | NT$1.09 Billion | NT$825.58 Million | NT$65.83 Million | ▼ -0.8 pp |
| 2017 | 70.3% | NT$1.00 Billion | NT$1.42 Billion | NT$1.07 Billion | NT$69.72 Million | ▼ -23.9 pp |
| 2016 | 94.2% | NT$636.30 Million | NT$675.62 Million | NT$757.37 Million | NT$121.06 Million | ▼ -2.3 pp |
| 2015 | 96.5% | NT$426.26 Million | NT$441.60 Million | NT$559.75 Million | NT$133.48 Million | ▼ -7.7 pp |
| 2014 | 104.2% | NT$888.23 Million | NT$852.14 Million | NT$1.04 Billion | NT$147.99 Million | ▼ -51.7 pp |
| 2013 | 155.9% | NT$239.72 Million | NT$153.77 Million | NT$429.23 Million | NT$189.51 Million | ▲ +23.0 pp |
| 2012 | 132.9% | NT$495.48 Million | NT$372.80 Million | NT$678.30 Million | NT$182.82 Million | ▲ +41.6 pp |
| 2011 | 91.3% | NT$468.81 Million | NT$513.21 Million | NT$554.89 Million | NT$86.08 Million | ▼ -12.8 pp |
| 2010 | 104.2% | NT$-4.47 Billion | NT$-4.29 Billion | NT$923.10 Million | NT$5.39 Billion | — |